Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Coeptis Therapeutics Holdings Inc
COEP
Alternate Symbol(s):
COEPW
Healthcare
Biotechnology
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio and rights are licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, natural killer cell therapy...
technology. Its product pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy; and SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological and solid tumors. In addition, the company offers its drugs for acute myeloid leukemia and acute ...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:COEP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(14)
•••
MasterJediJazz2
X
Post by
MasterJediJazz2
on Feb 07, 2025 10:00am
$COEP This additional financing enables Coeptis greatly!
$COEP "This additional financing enables Coeptis to not just fortify its mission in cell therapy but also empowers us to drive innovation in technology and AI," added Dave Mehalick
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 06, 2025 8:08am
New Press Release - COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration
WEXFORD, Pa., Feb. 6, 2025 /PRNewswire/ -- COEPTIS, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a pioneering technology company dedicated to advancing cutting-edge technologies and artificial intelligence at the forefront of innovative biotechnology therapeutic solutions, today announced...
read article.
(14)
•••
MasterJediJazz2
X
Post by
MasterJediJazz2
on Feb 05, 2025 1:25pm
$COEP Coeptis Therapeutics Holdings (Nasdaq: COEP) summary:
$COEP Coeptis Therapeutics Holdings (Nasdaq: COEP), a biopharmaceutical company specializing in cell therapy platforms, has announced the expansion of its technological initiatives to include
...more
(14)
•••
MasterJediJazz2
X
Post by
MasterJediJazz2
on Jan 31, 2025 12:03pm
$COEP Coeptis Therapeutics Leverages Artificial Intelligence
$COEP Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation https://prn.to/40WaHJG @coeptistx @Nasdaq
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 30, 2025 8:27am
New Press Release - Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Rebranding Signals Strategic Shift Beyond Biopharmaceuticals, Highlights Commitment to Technology, Artificial Intelligence and Shareholder ValueWEXFORD, Pa., Jan. 30, 2025 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company...
read article.
(14)
•••
MasterJediJazz2
X
Post by
MasterJediJazz2
on Jan 28, 2025 1:28pm
$COEP Coeptis Harnesses AI Advances and Blockchain!
$COEP Coeptis Harnesses AI Advances and Blockchain Initiatives to Drive Operational Efficiency and Strategic Growth https://coeptis.investorroom.com/2025-01-23-Coeptis-Therapeutics-Leverages
...more
(14)
•••
MasterJediJazz2
X
Post by
MasterJediJazz2
on Jan 27, 2025 2:48pm
$COEP $13.05 +9.53% HOD $13.60 @marketwatch #daily #recap
$COEP $13.05 +9.53% HOD $13.60 @marketwatch https://marketwatch.com/investing/stock/coep #nasdaq @nasdaq
(14)
•••
MasterJediJazz2
X
Post by
MasterJediJazz2
on Jan 27, 2025 9:04am
$COEP #BULLISH @Nasdaq @coeptistx 5-Day Perf.+28.48% !!
$COEP #BULLISH @Nasdaq @coeptistx 5-Day Perf.+28.48% and 1-Month Perf.+319.37% 3-Month Perf.+182.23% and 6-Month Perf.+116.78% YTD Perf.+116.55% Add to your portfolio #BuyNow
(14)
•••
MasterJediJazz2
X
Post by
MasterJediJazz2
on Jan 24, 2025 3:08pm
$COEP $12.18 +25.25% $COEP Coeptis Therapeutics Holdings
$COEP Coeptis Therapeutics Holdings (Nasdaq: COEP), a biopharmaceutical company specializing in cell therapy platforms, has announced the expansion of its technological initiatives to include
...more
(14)
•••
MasterJediJazz2
X
Post by
MasterJediJazz2
on Jan 24, 2025 9:36am
COEP Coeptis Harnesses AI Advances and Blockchain Initiative
$COEP Coeptis Harnesses AI Advances and Blockchain Initiatives to Drive Operational Efficiency and Strategic Growth https://stockhouse.com/news/press-releases/2025/01/23/coeptis-therapeutics-leverages
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 23, 2025 8:09am
New Press Release - Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation
Coeptis Harnesses AI Advances and Blockchain Initiatives to Drive Operational Efficiency and Strategic GrowthWEXFORD, Pa., Jan. 23, 2025 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy...
read article.
(14)
•••
MasterJediJazz2
X
Post by
MasterJediJazz2
on Jan 22, 2025 1:46pm
$COEP @coeptistx ' CEO Dave Mehalick statement today!
$COEP @coeptistx ' CEO Dave Mehalick stated today, "We thank the Nasdaq Hearings Panel for approving our request. Regaining compliance with Nasdaq's listing standards is an
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 22, 2025 8:01am
New Press Release - Coeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2)
WEXFORD, Pa., Jan. 22, 2025 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious diseases, today announced it has regained compliance with...
read article.
(14)
•••
MasterJediJazz2
X
Post by
MasterJediJazz2
on Jan 21, 2025 1:24pm
$COEP Coeptis Secures 5 New Clients W/Total Contract 1.7M!
$COEP Jan. 07, 2025 NEWS! @coeptistx Coeptis Therapeutics Holdings, Inc. (COEP) Coeptis Secures Five New Clients With Total Contract Value of $1.7 Million Dollars With More On The Horizon
...more
(14)
•••
MasterJediJazz2
X
Post by
MasterJediJazz2
on Jan 16, 2025 1:42pm
$COEP Dave Mehalick, Chairman, President & CEO of Coeptis
$COEP Dave Mehalick, Chairman, President & CEO of Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), discusses the company's innovative approaches in cell therapy, highlighting their focus on
...more
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mt Todd has emerged as one of the most compelling undeveloped gold assets globally
Environmental technology company enters a new strategic phase focused on scale and profitability
Lode Gold Enters into Exclusive LOI with a Mining Company to Advance Fremont Gold Project